Platelet factor 4 gene transfection into tumor cells inhibits angiogenesis, tumor growth and metastasis

Anticancer Research

Volumn 25, Issue 2 A, 2005, Pages 847-851

  Yamaguchi, Kentaro ^a   Ogawa, Kenji ^a   Katsube, Takao ^a   Shimao, Kazuya ^a   Konno, Soichi ^a   Shimakawa, Takeshi ^a   Yoshimatsu, Kazuhiko ^a   Naritaka, Yoshihiko ^a   Yagawa, Hirokazu ^a   Hirose, Kunitaka ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KUREHA CORPORATION   (Japan)

Author keywords

Anti angiogenesis; Chemokine; Platelet factor 4 (PF4)

Indexed keywords

ANGIOGENESIS INHIBITOR; COMPLEMENTARY DNA; THROMBOCYTE FACTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DNA TRANSFECTION; ENDOTHELIUM CELL; EXPRESSION VECTOR; HUMAN; IN VIVO STUDY; LEWIS CARCINOMA; LUNG METASTASIS; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR CELL; TUMOR VASCULARIZATION; WEIGHT;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL GROWTH PROCESSES; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NIH 3T3 CELLS; PLATELET FACTOR 4; TRANSFECTION;

EID: 20244388146     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Folkman J: Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-1763, 1995.
2. Files JC, Malpass TW, Yee EK, Ritchie JL and Harker LA: Studies of human plate alpha-granule release in vivo. Blood 58: 607-618, 1981.
3. Miller MD and Krangel MS: Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 72: 17-46, 1992.
4. Baggiolini M, Dewald B and Moser B: Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55: 97-179, 1994.
5. Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD and Stricter RM: CXC chemokines in angiogenesis. J Leukoc Biol 68: 1-8, 2000.
6. Rossi D and Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol 18: 217-242, 2000.
7. Baggiolini M: Chemokines and leukocyte traffic. Nature 392: 565-568, 1998.
8. Szekanecz Z, Shah MR, Harlow LA, Pearce WH and Koch AE: Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. The possible role of these cytokines in human aortic aneurysmal blood vessel growth. Pathobiology 62: 134-139, 1994.
9. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA and Stricter RM: Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 179: 1409-1415, 1994.
10. Gupta SK and Singh JP: Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression. J Cell Biol 127: 1121-1127, 1994.
11. Stricter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan SY, Roczniak S and Shanafelt AB: The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270: 27348-27357, 1995.
12. Watson JB, Getzler SB and Mosher DF: Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor. J Clin Invest 94: 261-268, 1994.
13. Gengrinovitch S, Greenberg SM, Cohen T, Gitay-Goren H. Rockwell P, Maione TE, Levi BZ and Neufeld G: Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms. J Biol Chem 270: 15059-15065, 1995.
14. Maione TE, Gray GS, Hunt AJ and Sharpe RJ: Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res 57: 2077-2083, 1991.
15. Hansell P, Maione TE and Borgstrom P: Selective binding of platelet factor 4 to regions of active angiogenesis in vivo. Am J Physiol 269: H829-836, 1995.
16. Sharpe RJ, Byers HR, Scott CF, Bauer SI and Maione TE: Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst 82: 848-853, 1990.
17. Tanaka T, Manome Y, Wen P, Kufe DW and Fine HA: Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth. Nat Med 3: 437-442, 1997.
18. Sato Y, Abe M and Takaki R: Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells. Biochem Biophys Res Commun 172: 595-600, 1990.
19. Gunning P, Leavitt J, Muscat G, Ng SY and Kedes L: A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci USA 84: 4831-4835, 1987.
20. Leek RD, Harris AL and Lewis CE: Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukoc Biol 56: 423-435, 1994.
21. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF and Sharpe RJ: Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247: 77-79, 1990.
22. Luster AD, Greenberg SM and Leder P: The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 152: 219-231, 1995.
23. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG and Stricter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801, 1992.
24. Kolber DL, Knisely TL and Maione TE: Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4. J Natl Cancer Inst 87: 304-309, 1995.
25. Soncin F, Shapiro R and Fett JW: A cell-surface proteoglycan mediates human adenocarcinoma HT-29 cell adhesion to human angiogenin. J Biol Chem 269: 8999-9005, 1994.